siRNA, Anti-DNTT, 2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT06197WQ-2OMe)

The product SIRGT06197WQ-2OMe is a type of small interfering RNA (siRNA) that targets DNTT gene and regulates the expression of gene. The siRNA interferes with the expression of DNTT gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001017520.1; NM_004088.3
Alternative Names TDT
Related Diseases Lymphoblastic Lymphoma, Myeloid Sarcoma
Purification HPLC
Target Gene
Gene ID 1791
Uniprot ID P04053
Sub Cat Target Species Modification Scale  
SIRGT08197WQ-2MOE DNTT Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT09197WQ-LNA DNTT Human Locked Nucleic Acid (LNA) Inquiry
SIRGT06197WQ-RB DNTT Human Ribo-modified Inquiry
SIRGT07197WQ-BB DNTT Human Backbone-modified Inquiry

Related Products